Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Brain Cancer

The Vps33a gene regulates behavior and cerebellar Purkinje cell number. Brain Res. 2009 Apr 17;1266:18–28.
Selective transcriptional regulation of aromatase gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine. 2009 Apr;35(2):252–61.
Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol Aspects Med. 2008 Dec;29(6):415–22. Review.
1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007 Dec;85(3):255–62.
An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007 Mar 1;120(5):1123–8.
The influence of isoflavonoids on the antitumor activity of vitamin D3. Postepy Hig Med Dosw (Online). 2007;61:253–60. Review.
Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer. 2006 Nov 10;6:264.
The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther. 2006 Apr;110(1):117–34. Review.
Hypocalcemia associated with bone metastases in a patient with salivary-gland carcinoma. Nat Clin Pract Oncol. 2006 Feb;3(2):104–7.
Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analog. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):165–72.
Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res. 2005 Aug 1;11(15):5370–80.
Intracerebral schwannoma clinically and radiologically mimicking meningioma. Pathol Int. 2005 Aug;55(8):514–9.
Season of birth and risk of brain tumors in adults. Neurology. 2005 Apr 12;64(7):1317; author reply 1317.
Cerebral lipoma and the underlying cortex of the temporal lobe: pathological features associated with the malformation. Acta Neuropathol. 2005 Mar;109(3):339–45.
Osteoporosis and amenorrhea in a young patient with von Hippel-Lindau disease. Isr Med Assoc J. 2005 Jan;7(1):48–9.
Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors. Arch Pediatr Adolesc Med. 2004 May;158(5):491–6.
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol. 2003 Oct;34(10):994–1000.
Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway. Biochem Pharmacol. 2003 Jun 15;65(12):1943–55.
Anti-proliferative effects of 20-epi-vitamin-D3 analogue, KH1060 in human neuroblastoma: induction of RAR-beta and p21(Cip1). Cancer Lett. 2003 Feb 10;190(1):51–60.
Regional expression of p75NTR contributes to neurotrophin regulation of cerebellar patterning. Mol Cell Neurosci. 2003 Jan;22(1):1–13.
Various risks of osteoporosis in patients with pituitary adenomas. J Bone Miner Metab. 2003;21(2):91–7.
Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res. 2003;164:319–32. Review.
Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells. Brain Pathol. 2002 Oct;12(4):412–9.
Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res. 2002 Aug 2;945(2):181–90.
Calbindin-d(28k): a marker of recurrence for medulloblastomas. Cancer. 2002 Jul 15;95(2):410–9.
Brain-derived neurotrophic factor modulates cerebellar plasticity and synaptic ultrastructure. J Neurosci. 2002 Feb 15;22(4):1316–27.
Vitamin D and genomic stability. Mutat Res. 2001 Apr 18;475(1–2):69–87. Review.
Heterogeneity in genetic susceptibility to prostate cancer. Eur J Intern Med. 2001 Feb;12(1):11–16.
Recovery from severe glucocorticoid-induced osteoporosis in an adolescent boy. J Clin Densitom. 2001 Winter;4(4):389–94.
Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha-hydroxycholecalciferol. J Neurooncol. 2001 Jan;51(1):57–66.
Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells. Biochem Pharmacol. 2000 Nov 1;60(9):1361–5.
Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol Endocrinol. 1999 Jul;13(7):1141–54.
Proliferation inhibition of glioma cells by vitamin K2. No Shinkei Geka. 1999 Feb;27(2):119–25.
Hypercalcemia in an euthyroid patient with secondary hypoadrenalism and diabetes insipidus due to hypothalamic tumor. Endocr J. 1998 Dec;45(6):773–8.
Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells. Acta Neurochir (Wien). 1998;140(7):707–13; discussion 713–4.
Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol. 1997 Nov;151(5):1477–86.
Tissue-specific expression and regulation by 1,25(OH)2D3 of chick protein kinase inhibitor (PKI) mRNA. Endocrine. 1997 Feb;6(1):5–10.
Noradrenaline inhibits the programmed cell death induced by 1,25-dihydroxyvitamin D3 in glioma. Eur J Pharmacol. 1997 Jan 29;319(2–3):365–8.
1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Brain Res Mol Brain Res. 1996 Sep 5;41(1–2):259–68.
Late-onset idiopathic hypoparathyroidism with thymoma: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1996 Feb;57(2):146–51.
1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells. J Endocrinol. 1995 Dec;147(3):397–404.
Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol. 1995 Sep;54(5):689–97.
Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med. Arch Pathol Lab Med. 1995 Aug;119(8):734–43.
Effects of vitamin D and retinoic acid on human glioblastoma cell lines. Acta Neurochir (Wien). 1995;133(3–4):184–90.
Medulloblastoma. Semin Diagn Pathol. 1994 May;11(2):85–97. Review.
Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? J Neurosci Res. 1994 Feb 1;37(2):271–7.
The expression of genes of the steroid-thyroid hormone receptor superfamily in central nervous system tumors. Anticancer Res. 1993 Jul–Aug;13(4):859–66.
Parvalbumin and calbindin D-28K immunoreactivity in central ganglioglioma and dysplastic gangliocytoma of the cerebellum. Report of two cases. J Neurosurg. 1993 Jan;78(1):133–7.
Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron. 1992 Nov;9(5):943–54.
Vitamin D receptor expression in human brain tumors. J Neurosurg Sci. 1992 Jan–Mar;36(1):27–30.
Subtractive cloning of a hybrid human endogenous retrovirus and calbindin gene in the prostate cell line PC3. Cancer Res. 1991 Aug 1;51(15):4107–10.
An emerging view of vitamin D. Scand J Clin Lab Invest Suppl. 1990;201:127–33. Review.
Vitamin D-induction of secretory responses in rat pituitary tumour (GH4C1) cells. J Endocrinol. 1988 May;117(2):293–8.
Hypercalcaemia in cerebellar medulloblastoma: pathogenesis of solid tumour-associated hypercalcaemia. Eur J Pediatr. 1987 Jul;146(4):434–6.
Synthesis of plasma proteins in fetal, adult, and neoplastic human brain tissue. Dev Biol. 1986 May;115(1):93–104.
Glucocorticoids antagonize induction of prolactin-gene expression by calcitriol in rat pituitary tumour cells. Biochem J. 1986 Jan 15;233(2):513–8.
An acromegalic patient with recurrent urolithiasis. Endocrinol Jpn. 1985 Dec;32(6):851–61.
Is there a relation between prolactin and vitamin D? Cas Lek Cesk. 1985 Jul 19;124(29):914–6.
Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med. 1984 Sep;77(3):501–12.
Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab. 1983 Jun;56(6):1120–3.
Modern therapy of seizures in childhood. Z Arztl Fortbild (Jena). 1964 Mar 15;58:308–15.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.